Jeffrey Kindler - Mar 9, 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Mar 9, 2023
Transactions value $
$69,000
Form type
4
Date filed
3/13/2023, 05:04 PM
Previous filing
Feb 24, 2023
Next filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award $69K +59K +21.37% $1.17 335K Mar 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +107K $0.00 107K Mar 9, 2023 Common Stock 107K Direct F2, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +125K $0.00 125K Mar 9, 2023 Common Stock 125K $1.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $69,000.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vested in full on March 9, 2024.